FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075768476> ?p ?o ?g. }

• W2075768476 endingPage "128" @default.
• W2075768476 startingPage "119" @default.
• W2075768476 abstract "Previous randomized trials have shown a benefit with concurrent use of the hypoxic cell cytotoxin mitomycin C (MC) and radiation (RT) in the management of squamous cell cancer of the head and neck (SCCHN). We conducted a randomized trial comparing MC with porfiromycin (POR) in combination with RT in the management of SCCHN.Between 1992 and 1999, 128 patients with SCCHN were enrolled in this prospective randomized trial. Patients were stratified by management intent, and balanced with respect to stage and site of disease. They were randomized to receive MC (15 mg/M(2)) or POR (40 mg/M(2)) on Days 5 and 47 (or last day) of RT. Of 121 evaluable patients, 61 were randomized to MC and 60 to POR. Patients were treated with standard daily RT to a total median dose of 64 Gy over 47 days. Patients were well balanced with respect to management intent, stage, site, age, sex, hemoglobin levels, tumor grade, radiation dose, and days on treatment.There were no significant differences between the two arms with respect to acute hematologic or nonhematologic toxicities. As of January 2003 with a median follow-up of 6.3 years, there have been 19 local relapses (4 MC vs. 15 POR), 21 regional relapses (7 MC vs. 14 POR), 24 distant metastases (11 MC vs. 13 POR), and 66 deaths (33 MC vs. 33 POR). MC was superior to POR with respect to 5-year local relapse-free survival (91.6% vs. 72.7%, p = 0.01), local-regional relapse-free survival (82% vs. 65.3%, p = 0.05), and disease-free survival (72.8% vs. 52.9%, p = 0.026). There were no significant differences between the two arms with respect to overall survival (49.2% vs. 54.4%) or distant metastasis-free rate (79.9% vs. 75.9%).Despite promising preclinical data, and an acceptable toxicity profile, POR was inferior to MC as an adjunct to RT in the management of SCCHN. This randomized trial emphasizes the need for randomized studies to evaluate new agents in the management of SCCHN." @default.
• W2075768476 created "2016-06-24" @default.
• W2075768476 creator A5001355711 @default.
• W2075768476 creator A5002935188 @default.
• W2075768476 creator A5027094411 @default.
• W2075768476 creator A5036073927 @default.
• W2075768476 creator A5037482302 @default.
• W2075768476 creator A5043512123 @default.
• W2075768476 creator A5059312310 @default.
• W2075768476 creator A5063899863 @default.
• W2075768476 creator A5067569965 @default.
• W2075768476 creator A5080919281 @default.
• W2075768476 creator A5090173345 @default.
• W2075768476 date "2005-01-01" @default.
• W2075768476 modified "2023-10-03" @default.
• W2075768476 title "Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: Final results of a randomized clinical trial" @default.
• W2075768476 cites W1759456481 @default.
• W2075768476 cites W1913074237 @default.
• W2075768476 cites W1956256739 @default.
• W2075768476 cites W1971211622 @default.
• W2075768476 cites W1974156374 @default.
• W2075768476 cites W1977306578 @default.
• W2075768476 cites W1984051969 @default.
• W2075768476 cites W1986884101 @default.
• W2075768476 cites W1991585972 @default.
• W2075768476 cites W1996078558 @default.
• W2075768476 cites W1997340681 @default.
• W2075768476 cites W2005133413 @default.
• W2075768476 cites W2005823857 @default.
• W2075768476 cites W2009210032 @default.
• W2075768476 cites W2009810780 @default.
• W2075768476 cites W2010620134 @default.
• W2075768476 cites W2022342238 @default.
• W2075768476 cites W2029923264 @default.
• W2075768476 cites W2037133431 @default.
• W2075768476 cites W2038864978 @default.
• W2075768476 cites W2043945205 @default.
• W2075768476 cites W2053469511 @default.
• W2075768476 cites W2053951681 @default.
• W2075768476 cites W2056500654 @default.
• W2075768476 cites W2059376449 @default.
• W2075768476 cites W2070961078 @default.
• W2075768476 cites W2078591171 @default.
• W2075768476 cites W2080091062 @default.
• W2075768476 cites W2083402073 @default.
• W2075768476 cites W2087704303 @default.
• W2075768476 cites W2092201775 @default.
• W2075768476 cites W2102940690 @default.
• W2075768476 cites W2124797202 @default.
• W2075768476 cites W2125710286 @default.
• W2075768476 cites W2125919881 @default.
• W2075768476 cites W2128874029 @default.
• W2075768476 cites W2131292435 @default.
• W2075768476 cites W2139554459 @default.
• W2075768476 cites W2145703501 @default.
• W2075768476 cites W2145953677 @default.
• W2075768476 cites W2146148650 @default.
• W2075768476 cites W2153965661 @default.
• W2075768476 cites W2155019837 @default.
• W2075768476 cites W2168534106 @default.
• W2075768476 cites W2168607632 @default.
• W2075768476 cites W2183899931 @default.
• W2075768476 cites W2187668060 @default.
• W2075768476 cites W2331395194 @default.
• W2075768476 cites W2344548402 @default.
• W2075768476 cites W2461208580 @default.
• W2075768476 cites W4247452643 @default.
• W2075768476 cites W4293241248 @default.
• W2075768476 cites W4300876838 @default.
• W2075768476 doi "https://doi.org/10.1016/j.ijrobp.2004.07.730" @default.
• W2075768476 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15629602" @default.
• W2075768476 hasPublicationYear "2005" @default.
• W2075768476 type Work @default.
• W2075768476 sameAs 2075768476 @default.
• W2075768476 citedByCount "50" @default.
• W2075768476 countsByYear W20757684762012 @default.
• W2075768476 countsByYear W20757684762013 @default.
• W2075768476 countsByYear W20757684762014 @default.
• W2075768476 countsByYear W20757684762016 @default.
• W2075768476 countsByYear W20757684762017 @default.
• W2075768476 countsByYear W20757684762019 @default.
• W2075768476 countsByYear W20757684762020 @default.
• W2075768476 countsByYear W20757684762021 @default.
• W2075768476 countsByYear W20757684762022 @default.
• W2075768476 countsByYear W20757684762023 @default.
• W2075768476 crossrefType "journal-article" @default.
• W2075768476 hasAuthorship W2075768476A5001355711 @default.
• W2075768476 hasAuthorship W2075768476A5002935188 @default.
• W2075768476 hasAuthorship W2075768476A5027094411 @default.
• W2075768476 hasAuthorship W2075768476A5036073927 @default.
• W2075768476 hasAuthorship W2075768476A5037482302 @default.
• W2075768476 hasAuthorship W2075768476A5043512123 @default.
• W2075768476 hasAuthorship W2075768476A5059312310 @default.
• W2075768476 hasAuthorship W2075768476A5063899863 @default.
• W2075768476 hasAuthorship W2075768476A5067569965 @default.
• W2075768476 hasAuthorship W2075768476A5080919281 @default.
• W2075768476 hasAuthorship W2075768476A5090173345 @default.
• W2075768476 hasConcept C121608353 @default.

• next